Skip to content
← Back to this collection

PUBLICATIONS · 6953986

Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
1982 Aug
First author
Yates J

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Yates J
      type
      Author
    2. name
      Glidewell O
      type
      Author
    3. name
      Wiernik P
      type
      Author
    4. name
      Cooper MR
      type
      Author
    5. name
      Steinberg D
      type
      Author
    6. name
      Dosik H
      type
      Author
    7. name
      Levy R
      type
      Author
    8. name
      Hoagland C
      type
      Author
    9. name
      Henry P
      type
      Author
    10. name
      Gottlieb A
      type
      Author
    11. name
      Cornell C
      type
      Author
    12. name
      Berenberg J
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Yates J
      type
      Author
    2. name
      Glidewell O
      type
      Author
    3. name
      Wiernik P
      type
      Author
    4. name
      Cooper MR
      type
      Author
    5. name
      Steinberg D
      type
      Author
    6. name
      Dosik H
      type
      Author
    7. name
      Levy R
      type
      Author
    8. name
      Hoagland C
      type
      Author
    9. name
      Henry P
      type
      Author
    10. name
      Gottlieb A
      type
      Author
    11. name
      Cornell C
      type
      Author
    12. name
      Berenberg J
      type
      Author
    bibliography ids
    1. nci-bib-18268fc7efcd15031d7a3c1e
    book metadata
    content sha256
    2ba4a2071dddc83b86dfb75f9f2d5110fb5acb66bb6c0ebd3b4707d3c0bff1a2
    document type
    citation
    dois
      electronic publication date
      display
      Source null
      precision
      missing
      year
      Source null
      evidence scope
      bibliographic_metadata_only
      id
      pubmed:6953986
      immutable id
      pubmed:6953986@2ba4a2071dddc83b86dfb75f9f2d5110fb5acb66bb6c0ebd3b4707d3c0bff1a2
      journal
      abbreviation
      Blood
      issn electronic
      Source null
      issn print
      0006-4971
      issue
      2
      name
      Blood
      nlm unique id
      7603509
      pages
      454-62
      volume
      60
      languages
      1. eng
      notices
      absence is not clearance
      true
      has correction metadata
      false
      has expression of concern metadata
      false
      has retraction in link
      false
      pubmed marks article retracted
      false
      pubmed marks retraction notice
      false
      relationships
        outcomes validated
        false
        pmid
        6953986
        provenance
        batch id
        45403cd8e23f91d9edb9
        provider
        NCBI PubMed ESummary
        record sha256
        d02de2ca24cce0fb4b7244370448eed0c5a3f4919d733a3a4485a5774327e80b
        response sha256
        67aea2123a1ac51343b6dac62187e007efabbd6172b000ecba1c9d0afe20513a
        retrieved at
        2026-09-09T23:45:14.686855+00:00
        publication date
        display
        1982 Aug
        precision
        month
        year
        1982
        publication types
        1. Clinical Trial
        2. Journal Article
        3. Randomized Controlled Trial
        4. Research Support, U.S. Gov't, P.H.S.
        record status
        PubMed - indexed for MEDLINE
        schema version
        1.0
        source url
        https://pubmed.ncbi.nlm.nih.gov/6953986/
        title
        Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study.

        Preserved source evidence · Not medical advice